An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma

Journal of Molecular Diagnostics

Volumn 12, Issue 4, 2010, Pages 461-468

  Onken, Michael D ^a   Worley, Lori A ^a   Tuscan, Meghan D ^a   Harbour, J William ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HYBRIDIZATION; MAJOR CLINICAL STUDY; METASTASIS; MICROARRAY ANALYSIS; MULTIGENE FAMILY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIMARY TUMOR; PROGNOSIS; PROSPECTIVE STUDY; UVEA MELANOMA; BIOASSAY; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENETICS; KAPLAN MEIER METHOD; MELANOMA; PATHOLOGY; PROCEDURES; STANDARD; STANDARDS; TUMOR GENE; UVEA; UVEA TUMOR;

BIOLOGICAL ASSAY; BIOPSY, FINE-NEEDLE; FEASIBILITY STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC HETEROGENEITY; HUMANS; KAPLAN-MEIER ESTIMATE; MELANOMA; NEOPLASM METASTASIS; REFERENCE STANDARDS; RNA, NEOPLASM; UVEA; UVEAL NEOPLASMS;

EID: 77954355725     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2010.090220     Document Type: Article

References (36)

1. Harbour JW: Clinical overview of uveal melanoma: introduction to tumors of the eye. Edited by Albert DM, Polans A. New York, Marcel Dekker, 2003, pp. 1-18
2. Cook SA, Damato B, Marshall E, Salmon P: Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye 2008, 23:581-585
3. Onken MD, Worley LA, Ehlers JP, Harbour JW: Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004, 64:7205-7209
4. Chang SH, Worley LA, Onken MD, Harbour JW: Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008, 18:191-200
5. Onken MD, Worley LA, Davila RM, Char DH, Harbour JW: Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens. J Mol Diagn 2006, 8:567-573
6. Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW: Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 2007, 13:1466-1471 (Pubitemid 46450436)
7. Petrausch U, Martus P, Tonnies H, Bechrakis NE, Lenze D, Wansel S, Hummel M, Bornfeld N, Thiel E, Foerster MH, Keilholz U: Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye 2008, 22:997-1007
8. van Gils W, Lodder EM, Mensink HW, Kilic E, Naus NC, Bruggenwirth HT, van Ijcken W, Paridaens D, Luyten GP, de Klein A: Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci 2008, 49:4254-4262
9. Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, Harbour JW: Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 2006, 66:4602-4609
10. Faulkner-Jones BE, Foster WJ, Harbour JW, Smith ME, Daivila RM: Fine needle aspiration biopsy with adjunct immunohistochemistry in intraocular tumor management. Acta Cytol 2005, 49:297-308 (Pubitemid 40677530)
11. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:research0034.0031 - research0034.0011
12. Wackerly DD, Mendenhall W, Scheaffer RL: Mathematical statistics with applications. Duxbury, Belmont Press, 1996
13. Schoenfield L, Pettay J, Tubbs RR, Singh AD: Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med 2009, 133:1219-1222
14. Maat W, Jordanova ES, van Zelderen-Bhola SL, Barthen ER, Wessels HW, Schalij-Delfos NE, Jager MJ: The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med 2007, 131:91-96 (Pubitemid 46174141)
15. Mensink HW, Vaarwater J, Kilic E, Naus NC, Mooy N, Luyten G, Bruggenwirth HT, Paridaens D, de Klein A: Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci 2009, 50:500-504
16. Damato B, Coupland SE: Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol 2009, 127:423-429
17. Ehlers JP, Harbour JW: NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res 2005, 11:1849-1853 (Pubitemid 40471849)
18. Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, Ares M Jr, Haussler D: Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A 2000, 97:262-267
19. Cussac D, Boutet-Robinet E, Ailhaud M-C, Newman-Tancredi A, Martel J-C, Danty N, Rauly-Lestienne I: Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. Eur J Pharmacol 2008, 594:32-38
20. Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW: Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008, 49:5230-5234
21. Russell RG, Lasorella A, Dettin LE, Iavarone A: Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Res 2004, 64:7220-7225
22. Tsunedomi R, Iizuka N, Tamesa T, Sakamoto K, Hamaguchi T, Somura H, Yamada M, Oka M: Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Clin Cancer Res 2008, 14:1025-1031
23. Di Benedetto M, Bièche I, Deshayes F, Vacher S, Nouet S, Collura V, Seitz I, Louis S, Pineau P, Amsellem-Ouazana D, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Lidereau R, Nahmias C: Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins. ATIP. Gene 2006, 380:127-136
24. Wang L, Yu J, Ni J, Xu X-M, Wang J, Ning H, Pei X-F, Chen J, Yang S, Underhill CB, Liu L, Liekens J, Merregaert J, Zhang L: Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Letters 2003, 200:57-67
25. Jia L, Cheng L, Raper J: Slit/Robo signaling is necessary to confine early neural crest cells to the ventral migratory pathway in the trunk. Dev Biol 2005, 282:411-421
26. Legg J, Herbert J, Clissold P, Bicknell R: Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis 2008, 11:13-21
27. Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, Dejean A, Galande S: Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 2007, 9:45-56
28. Brock TG, Maydanski E, McNish RW, Peters-Golden M: Co-localization of leukotriene A4 hydrolase with 5-lipoxygenase in nuclei of alveolar macrophages and rat basophilic leukemia cells but not neutrophils. J Biol Chem 2001, 276:35071-35077
29. Okano-Mitani H, Ikai K, Imamura S: Human melanoma cells generate leukotrienes B4 and C4 from leukotriene A4. Arch Dermatol Res 1997, 289:347-351
30. Lian Z, Pan J, Liu J, Zhang S, Zhu M, Arbuthnot P, Kew M, Feitelson MA: The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene 1999, 18:1677-1687
31. Ng EL, Wang Y, Tang BL: Rab22B's role in trans-Golgi network membrane dynamics. Biochem Biophys Res Comm 2007, 361:751-757
32. Ivanov I, Lo KC, Hawthorn L, Cowell JK, Ionov Y: Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells. Oncogene 2006, 26:2873-2884 (Pubitemid 46701445)
33. Rath N, Wang Z, Lu MM, Morrisey EE: LMCD1/Dyxin is a novel transcriptional cofactor that restricts gata6 function by inhibiting DNA binding. Mol Cell Biol 2005, 25:8864-8873 (Pubitemid 41429078)
34. Singh AD, Sisley K, Xu Y, Li J, Faber P, Plummer SJ, Mudhar HS, Rennie IG, Kessler PM, Casey G, Williams BG: Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol 2007, 91:1385-1392
35. Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe'er J: Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Ophthalmol Vis Sci 2006, 47:802-806
36. van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA: Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 2003, 106:472-479